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Abstract
Background: The ETS family transcription factor ESE-1 is often overexpressed in human breast cancer. ESE-1
initiates transformation of MCF-12A cells via a non-transcriptional, cytoplasmic process that is mediated by a
unique 40-amino acid serine and aspartic acid rich (SAR) subdomain, whereas, ESE-1’s nuclear transcriptional
property is required to maintain the transformed phenotype of MCF7, ZR-75-1 and T47D breast cancer cells.
Results: To map the minimal functional nuclear localization (NLS) and nuclear export (NES) signals, we fused in-
frame putative NLS and NES motifs between GFP and the SAR domain. Using these GFP constructs as reporters of
subcellular localization, we mapped a single NLS to six basic amino acids (
242HGKRRR
247) in the AT-hook and two
CRM1-dependent NES motifs, one to the pointed domain (NES1:
102LCNCALEELRL
112) and another to the DNA
binding domain (DBD), (NES2:
275LWEFIRDILI
284). Moreover, analysis of a putative NLS located in the DBD
(
316GQKKKNSN
323) by a similar GFP-SAR reporter or by internal deletion of the DBD, revealed this sequence to lack
NLS activity. To assess the role of NES2 in regulating ESE-1 subcellular localization and subsequent transformation
potency, we site-specifically mutagenized NES2, within full-length GFP-ESE-1 and GFP-NES2-SAR reporter constructs.
These studies show that site-specific mutation of NES2 completely abrogates ESE-1 transforming activity.
Furthermore, we show that exclusive cytoplasmic targeting of the SAR domain is sufficient to initiate transformation,
and we report that an intact SAR domain is required, since block mutagenesis reveals that an intact SAR domain is
necessary to maintain its full transforming potency. Finally, using a monoclonal antibody targeting the SAR domain,
we demonstrate that the SAR domain contains a region accessible for protein - protein interactions.
Conclusions: These data highlight that ESE-1 contains NLS and NES signals that play a critical role in regulating its
subcellular localization and function, and that an intact SAR domain mediates MEC transformation exclusively in
the cytoplasm, via a novel nontranscriptional mechanism, whereby the SAR motif is accessible for ligand and/or
protein interactions. These findings are significant, since they provide novel molecular insights into the functions of
ETS transcription factors in mammary cell transformation.
Background
The human ETS (E26 Transformation-Specific) protein
family is a diverse group of 27 known transcription factors
that regulate such varied cellular processes as differentia-
tion and apoptosis, but also appear to induce oncogenesis
when mutated or aberrantly expressed [1-4]. In particular,
aberrant ETS protein activity and/or expression has been
implicated in human mammary epithelial cell (MEC)
transformation [5]. The ER81 ETS protein, for example, is
activated in human breast cancer cells by the oncoprotein
HER-2, resulting in over-expression of the prosurvival tel-
omerase reverse transcriptase (hTERT) gene [6]. In addi-
tion, ETS-1 mRNA overexpression appears to be a strong
independent predictor of poor prognosis in primary
human breast cancers [7]. Furthermore, ETS-2 overex-
pression can inhibit expression of the tumor-suppressor
gene BRCA1, the downregulation of which is clearly linked
to familial breast cancer [7,8].
Overexpression of one ETS protein in particular, the
epithelium-specific ETS factor ESE-1, is implicated in
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expressed in primary human ductal carcinomas in situ
(DCIS), and the genomic ESE-1 locus (1q32.1) is com-
monly amplified in primary human breast cancer cells
[9-11]. In addition, we have shown that ESE-1 expres-
sion confers a transformed phenotype to the nontrans-
formed MCF-12A and MCF-10A human MECs,
including enhanced invasiveness and motility, anchorage
independent growth, epidermal growth factor-indepen-
dent proliferation, and formation of disorganized struc-
tures in three-dimensional cultures on matrigel [12-14].
A later study screening a collection cDNAs associated
with breast cancer independently identified ESE-1 as a
factor that promotes motility and induces formation of
disorganized structures on matrigel in MCF-10A cells
[15].
While previous publications have established ESE-1’s
transcription factor function, we have reported that ESE-
1 initiates transformation of MECs via a novel non-
nuclear, non-transcriptional mechanism [13]. We have
shown that a 40-amino acid (AA) serine and aspartic acid
rich (SAR) domain within the ESE-1 is both necessary
and sufficient to mediate ESE-1 transforming function
and that enforced nuclear localization of full-length ESE-
1 or of the SAR domain alone, abrogates ESE-1 ability to
initiate transformation [13]. These results imply that
ESE-1 contains an endogenous nuclear export signal that
is required for ESE-1-mediated initiation of MEC trans-
formation via a cytoplasmic mechanism. In addition to
transformation initiating function that requires cytoplas-
mic localization of ESE-1, we have reported that ESE-1 is
required for the maintenance of transformed phenotype
in breast cancer cell lines. We have shown that shRNA-
mediated downregulation of ESE-1 protein levels in
MCF7 and ZR-75-1 breast cancer cell lines results in
d e c r e a s e da n c h o r a g ei n d e p e n d e n tg r o w t h ,a n dt h a t
in these cells lines, as well as in T47D, ESE-1 is localized
to the nucleus [16]. Thus, nuclear function of ESE-1 is
required for the maintenance of transformed phenotype.
Together these reports establish that nuclear-cytoplasmic
shuttling of ESE-1 is essential for transformation initia-
tion in benign MECs as well as for the maintenance of
transformed phenotype in breast cancer cells, and imply
that ESE-1 contains both nuclear export (NES) as well as
nuclear localization (NLS) signals.
In the current report we use fusion between green
fluorescent protein (GFP) and specific ESE-1 motifs to
map functional ESE-1 NES and NLS sequences and to
define the role of these motifs in ESE-1 transforming
function. We localize the functional ESE-1 NLS to a six
AA basic motif within the ESE-1 A/T Hook domain and
we demonstrate that, unlike in other ETS proteins
[17-19], in-frame deletion of the ESE-1 DBD does not
abrogate ESE-1 nuclear localization. Using both gain-of-
function and loss-of-function approaches, we identify a
single NES within the ESE-1 DBD that is required for
ESE-1-mediated initiation of MCF-12A cell transforma-
tion. Furthermore, we sequentially mutagenize 11-14
A A sb l o c k si nt h eS A Rd o m a i nt oe s t a b l i s ht h a tw h i l e
each of the SAR mutants partially retains transformation
function in MCF-12A cells, an intact SAR domain is
required for its full transforming activity. Finally, we
identify ESE-1 region 216-228 within the SAR domain as
the site of interaction with anti-ESE-1 antibody mAB405,
what suggests that this region is surface exposed and
thus likely to mediate protein-protein interactions. In
summary, these data represent a paradigm shift in our
understanding of the specific subcellular functions of
ETS transcription factors, by revealing a novel NES2
and providing insights into SAR domain-dependent cyto-
plasmic mechanism by which ESE-1 initiates MEC
transformation.
Results
ESE-1 contains a single, basic amino acid-rich NLS that
maps to the A/T hook domain
The nuclear localization signal (NLS) in Elf3, the murine
ortholog of human ESE-1, has been mapped to four basic
residues
244KRKR
247 within the AT Hook domain [20],
with additional NLS motifs within the AT hook (AA 236-
252 and 249-267) and DBD (
318KKK
320) also contributing
to nuclear localization [21]. We have previously shown
that in-frame deletion of AA 231-268, spanning the AT
hook domain in human ESE-1, resulted in exclusive cyto-
plasmic localization [13]. To precisely map the functional
NLS motif(s) within human ESE-1 and to assess whether
these motif(s) are the same as in murine Elf3, we designed
a gain-of-function assay, in which each putative NLS was
fused between the GFP and SAR portions of the GFP-SAR
construct [13] and the resulting GFP signals were then
used as reporters of the subcellular localization of each
fusion protein in transiently transfected MCF-12A cells
(Figure 1). We identified one putative SV40-like NLS
(NLS1:
240PKHGKRKR
249), and two putative bipartite NLS
sequences (NLS2:
236KKGDPKHGKRKR
247 and NLS3,
251RKLSKEYWDCLEGKKSKH
268)( F i g u r e1 A ) ,w h i c h
were also in murine Elf3 [21]. Subsequently, we generated
GFP-NLS1-SAR, GFP-NLS2-SAR, and GFP-NLS3-SAR
fusion constructs, in which each putative NLS was fused
in-frame between GFP and a 189-239 AA fragment of
ESE-1 spanning the SAR domain and 10 AAs just distal to
the SAR domain (Figure 1A &1B). In transiently trans-
fected MCF-12A cells, GFP-SAR protein is distributed to
both the nuclear and cytoplasmic compartments (Figure
1C, panel 6) and [13]. In contrast, MCF-12A cells transi-
ently transfected with the NLS fusion constructs demon-
strate exclusive nuclear localization of GFP-NLS1-SAR
(Figure 1C, panel 1) and GFP-NLS2-SAR (Figure 1C,
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mic and nuclear (Figure 1C, panel 3) and is indistinguish-
able from GFP-SAR protein (Figure 1C, panel 6). Thus,
NLS1 and NLS2, but not NLS3, have intrinsic nuclear
localization function, narrowing ESE-1 nuclear localizing
activity to AA 236-249 (Figure 1A). To further localize
ESE-1 NLS activity, two plasmids with progressive amino-
terminal truncations of the ESE-1 NLS region were gener-
ated: pEGFP-NLS4-SAR and pEGFP-NLS5-SAR, in which
the ESE-1 sequences
241KHGKRKR
247 and
242HGKRKR
247
were fused between GFP and SAR, respectively (Figures
1A &1B). Transient expression of both GFP-NLS4-SAR
(Figure 1C, panel 4) and GFP-NLS5-SAR (Figure 1C,
panel 5) demonstrated exclusive nuclear localization in
MCF-12A cells. Taken together, these findings map more
precisely ESE-1 nuclear localizing activity to AA 242-247
and define the ESE-1 NLS as a six amino acid sequence
similar to the SV40 large T antigen NLS (PKKKRKV) [22].
Figure 1 ESE-1 contains a basic AA-rich NLS sequence. (A) Diagram of ESE-1 protein and sequence of the ESE-1 region containing putative
ESE-1 NLS motifs 1-5 (AAs 236-268). Colored boxes indicate ESE-1 domains. A red line below the diagram indicates localization of AAs 236-268,
with the sequence expanded below. AA sequences for putative ESE-1 NLS motifs 1-5 are aligned with the ESE-1 236-268 AA sequence. Red
letters - AAs potentially required for nuclear localization. Red line above diagram - localization of putative NLS6 motif. (B) Map and AA sequence
of GFP-NLS1-SAR. GFP (green box, not to scale) followed in-frame by NLS1 (red letters). The AA sequence for all but the first two amino acids in
the ESE-1 SAR domain (blue box) is fused to the carboxy-terminal end of NLS1, followed by ESE-1 flanking sequence (white box). All remaining
NLS fusion proteins were constructed the same way. (C) Representative fluorescence microscopy images of MCF-12A cells transiently transfected
with GFP-NLS1-SAR (panel 1), GFP-NLS2-SAR (panel 2), GFP-NLS3-SAR (panel 3), GFP-NLS4-SAR (panel 4), GFP-NLS5-SAR (panel 5), or GFP-SAR
(panel 6) (D) Left panel - AA sequence alignments among putative ESE-1 NLS6 and ETS-1, ELK-1, ER71 NLS motifs. Superscripted numbering
indicates the position of each AA sequence within its parental protein. Right panel - representative fluorescence microscopy images of MCF-12A
cells, transiently transfected with the GFP-NLS6-SAR. (E) Left panel - diagram of GFP-ESE-1ΔDBD. In-frame deletion of ESE-1 DBD is represented
by a V-shaped line. Right panel - representative MCF-12A cells transiently transfected with the GFP-ESE-1ΔDBD construct imaged by fluorescence
microscopy. In all images white dashed lines represent cell outlines.
Prescott et al. Molecular Cancer 2011, 10:103
http://www.molecular-cancer.com/content/10/1/103
Page 3 of 15Previous reports have shown that basic AA-rich
sequences in the DBDs of several different ETS pro-
teins, including ETS-1 (
376GKRKNKPK
383), ELK-1
(
47GLRKNKTN
54), and ER71 (
275GERKRKPG
282), med-
iate the nuclear localization of these proteins [17-19]. In
murine Elf3, internal deletion or site-specific mutation
of the
318KKK
320 sequence, within the context of the
entire DBD, resulted in the localization to both the
nucleus and the cytoplasm [21]. Considering these data,
we tested whether a similar putative NLS sequence,
316GQKKKNSN
323 (ESE-1 NLS6) in the ESE-1 DBD
also shows NLS function, using the GFP fusion strategy
described above (Figure 1D). Transient expression of
GFP-NLS6-SAR in MCF-12A cells revealed diffuse cyto-
plasmic and nuclear fluorescence (Figure 1D) that was
indistinguishable from that of GFP-SAR (Figure 1C,
panel 6) and [13], indicating that ESE-1 NLS6 is insuffi-
cient to mediate nuclear localization. To test whether
the ESE-1 NLS6 is necessary to mediate nuclear locali-
zation, we generated an additional construct in which
t h eE S E - 1D B Dw a sd e l e t e di n - f r a m ef r o mt h ep r e -
viously described pEGFP-ESE-1 expression plasmid,
containing the full-length ESE-1 protein, to generate
pEGFP-ESE-1ΔDBD (Figure 1E). Transient transfection
in MCF-12A cells revealed exclusive nuclear GFP-ESE-
1ΔDBD localization, thus demonstrating that in the
human ortholog of ESE-1, the DBD is not required for
ESE-1 nuclear localization. Together with the data
s h o w ni nF i g u r e s1 C&F i g u r e1 D ,t h e s ef i n d i n g si n d i -
cate that, unlike previously examined ETS proteins,
the ETS DBD does not play a role in ESE-1 nuclear
localization.
ESE-1 contains two separate CRM1-dependent NES motifs
Having shown that internal deletion of the AT hook
domain containing the functional NLS results in exclu-
sive cytoplasmic localization of ESE-1 [13], we specu-
lated that ESE-1 contains two putative NES signals
corresponding to the consensus sequence (L/I)X2-4(L/I)
X1-4(L/I)X(L/I) [23]:
102LCNCALEELRL
112 in the
Pointed domain (NES1) and
275LWEFIRDILI
284 in the
DBD (NES2) (Figure 2A). To test the function of these
NES motifs, we inserted each sequence in-frame
between the GFP and SAR portions of the GFP-SAR
construct to produce GFP-NES1-SAR and GFP-NES2-
SAR, respectively (Figure 2B) and we used the GFP
fluorescence as a reporter of subcellular localization.
MCF-12A cells transiently transfected with these con-
structs demonstrate a predominantly cytoplasmic locali-
zation for both the GFP-NES1-SAR and GFP-NES2-SAR
proteins (Figure 2C, panels 1, 2, 7 & 8). Thus, both the
ESE-1 NES1 and NES2 sequences are sufficient to med-
iate nuclear export. Because NES motifs conforming to
the (L/I)X2-4(L/I)X1-4(L/I)X(L/I) consensus sequence
activate nuclear export by binding directly to the CRM1
nuclear exporter protein [24], we next tested the role of
CRM1 in the nuclear export mediated by each ESE-1
NES motifs. MCF-12A cells transfected with the GFP-
NES1-SAR or GFP-NES2-SAR constructs were treated
with the CRM1-specific inhibitor leptomycin B [25],
which resulted in the redistribution of GFP-NES1-SAR
(Figure 2C, panels 3 & 4) and GFP-NES2-SAR (Figure
2C, panels 9 & 10), respectively, from the cytoplasm
both to the nuclear and cytoplasmic compartments.
This leptomycin B-induced inhibition of nuclear export
reveals that both ESE-1 NES motifs function via a
CRM1-dependent mechanism. The four conserved leu-
cine/isoleucine residues characterizing the NES (L/I)X2-
4(L/I)X1-4(L/I)X(L/I) sequence are known to play a cru-
cial role in the function of this motif [26]. Thus, we
next tested the functional importance of the conserved
leucine/isoleucine residues in each ESE-1 NES by engi-
neering two leucine/isoleucine-to-alanine mutations
within the NES sequences of the GFP-NES1-SAR and
GFP-NES2-SAR constructs (Figure 2B). NES1 was
altered from LCNCALEELRL to LCNCAAEEARL
(NES1Mut-SAR), and NES2 was altered from LWEFIR-
DILI to LWEFARDALI (NES2Mut-SAR). For both NES
mutant plasmids, the GFP signal was diffusely nuclear
and cytoplasmic (Figure 2C, panels 5, 6, 11 & 12),
mimicking the GFP-NES1-SAR and GFP-NES2-SAR
fluorescence patterns observed following leptomycin B
treatment (Figure 2C, panels 3 & 9). These data demon-
strate that the nuclear export function of each ESE-1
NES depends on conserved leucine/isoleucine residues
within each of the NES sequences.
Site-specific mutation of ESE-1 NES2 inhibits GFP-ESE-1-
induced MCF-12A cell transformation
Having shown that ESE-1 contains two separate, CRM1-
dependent NES signals (Figure 2), we next sought to
determine their role in the transforming function of full-
length ESE-1 (Figure 3). We have previously reported that
in-frame deletion of the ESE-1 Pointed domain, which
contains NES1 (AA 102-112, Figure 3A), does not impair
GFP-ESE-1-induced MCF-12A cell transformation [13].
Thus, the nuclear export function of NES1 is not required
for the transforming function of GFP-ESE-1, since ESE-1-
initiated transformation requires cytoplasmic localization,
and inactivation of the critical NES signals should elimi-
nate ESE-1 transforming activity. To test the role of NES2,
we generated the same inactivating NES2 mutations as
described for the GFP-NES2Mut-SAR construct (Figure
2B), but in the context of the full length ESE-1 protein
(Figure 3A). As expected, this GFP-ESE-1 NES2Mut pro-
tein is exclusively nuclear in transiently transfected MCF-
12A cells (Figure 3B). To test the effect of NES2 mutation
on GFP-ESE-1-mediated transformation, we generated
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for the GFP-ESE-1 NES2Mut construct, as well as for the
GFP-ESE-1 and GFP-only constructs. In addition, because
both the PEA-3 and ETS-2 ETS factors have been impli-
cated in human breast cancer (although neither contains a
SAR domain) we also fused GFP, in-frame, to the N-termi-
nus of each of these ETS proteins and used these two
fusions to test both their transforming potency and to
control for nonspecific transforming effects of ETS protein
expression in MCF-12A cells. Two independent MCF-12A
stable cell populations were generated for each GFP-PEA3
and GFP-ETS-2 constructs. Subsequently, soft agar colony
assays for all transfectant populations were performed in
triplicate. Representative colonies in each culture were
imaged at eight days (Figure 3C) and quantitated at 21
days (Figure 3D) post seeding. The GFP-only negative
control did not yield multicellular colonies at eight days,
whereas large multicellular colonies were formed by the
GFP-ESE-1 positive control (Figure 3C). Further, the GFP-
PEA3, GFP-ETS-2 and GFP-ESE-1 NES2Mut stable trans-
fectants produced colonies similar to those observed in
the GFP-only negative control. Colony quantitation for
each stable transfectant revealed that the GFP-only nega-
tive control produced on average 379 colonies per plate
and that the GFP-ESE-1 positive control formed 1239
colonies (Figure 3D). The GFP-PEA3 and GFP-ETS- 2
stable transfectants formed only 43 and 143 colonies,
respectively (Figure 3D), suggesting that these two fusion
proteins may exert a dominant negative effect on basal
MCF-12A cell growth in soft agarose. Finally, stable GFP-
ESE-1 NES2Mut expression resulted in only 350 colonies
(Figure 3D). These data indicate that NES2 mutation abro-
gates GFP-ESE-1 transforming function in MCF-12A cells,
confirming the colony imaging data shown in Figure 3C
and also demonstrating that NES1 cannot compensate for
lost NES2 function in full length ESE-1. Moreover, these
findings indicate that neither PEA-3 nor ETS-2 possess
transforming activity and that the nuclear export function
of NES2 is essential for full-length ESE-1 transforming
function in mammary epithelial cells. To confirm the
expression of each GFP-ETS fusion construct in respective
stable transfectants, we performed RT-PCR analysis and
we sequenced the resulting PCR products for all stable cell
populations described above. As shown in Figure 3E, these
RT-PCR studies revealed that the two independently gen-
erated GFP-only stable populations (GFP-only A and
GFP-only B) yielded only the expected 169-bp product.
Similarly, only the expected 1624-bp GFP-PEA3-specific
product was amplified from each GFP-PEA3 stable popu-
lation (PEA3 A and PEA3 B), and each GFP-ETS-2 stable
population demonstrated only the expected 1579-bp RT-
PCR product (ETS-2 A and ETS-2 B). The ESE-1 A, ESE-
Figure 2 ESE-1 contains two separate CRM-1 dependent NES motifs. (A) Block diagram of ESE-1 protein with domains indicated by labeled
colored boxes. NES1 and NES2 are represented by black lines above the diagram. (B) Schematic of GFP-NES1-SAR and GFP-NES2-SAR proteins,
constructed as described in Figure 1B. Green box - GFP. White box - NES1 or NES2. Critical NES leucine and isoleucine residues are shown in red.
Blue box followed by white box - ESE-1 fragment 190-239 containing the SAR domain (AAs 190-229). (C) Fluorescence imaging of transiently
expressed GFP-NES1-SAR (± leptomycin B; panels 1, 2, 3, & 4), GFP-NES1Mut-SAR (panels 5 and 6), GFP-NES-2-SAR (± leptomycin B; panels 7, 8, 9,
& 10), and GFP-NES2Mut-SAR (panels 11 & 12) in living MCF-12A cells. All transfectants were DAPI-stained to identify the nuclei and some GFP-
NES1-SAR and GFP-NES2-SAR transfectants were treated with leptomycin B prior to microscopy. Upper panels - GFP fluorescence (green). Lower
panels - overlays of GFP (green) and DAPI (blue) fluorescence. Although only one or two representative cells are shown for each transfectant
population, a ~30% transfection efficiency was consistently achieved per 10
6 cells transfected and ~10
5 green fluorescent cells were present
following each transfection. White dashed lines represent cell outlines.
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representing a corresponding stable transfectant popula-
tion, all exclusively demonstrated the same expected 1285-
bp RT-PCR product. The presence of DNA contamination
was assessed by treating total RNA from each stably trans-
fected GFP-PEA3 pool with RNAse A (PEA3 A (R) and
PEA3 B (R), respectively) prior to RT-PCR. Furthermore,
DNA sequencing of these RT-PCR products demonstrated
both the predicted in-frame GFP fusion and the absence
of mutations in each case (data not shown).
Stable expression of the GFP-NES1-SAR protein is
sufficient to transform MCF-12A cells
Using a GFP-fusion strategy similar to that described
above, we have shown that the SAR domain of ESE-1 is
both necessary and sufficient to mediate MCF-12A cell
transformation and that enforced nuclear localization of
the SAR domain abrogates this effect [13]. These data
suggest that the SAR domain transforms MCF-12A cells
via a cytoplasmic mechanism. Having generated GFP-
NES-SAR fusion constructs whose expression is
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Figure 3 Mutation of ESE-1 NES2 inhibits GFP-ESE-1-induced MCF-12A cell transformation. (A) Diagram of the GFP-ESE-1 protein showing
the two isoleucine to alanine point mutations engineered in the ESE-1 NES2 sequence to generate the GFP-ESE-1 NES2Mut construct. Black lines
above the diagram - NES1 or NLS. Red line below the diagram - NES2 (wild type NES2 sequence expanded below). Red letters - critical leucine and
isoleucine residues in NES2. Blue letters - the isoleucine to alanine point mutations engineered to generate NES2Mut. (B) Direct fluorescence
imaging of MCF-12A cells transiently expressing GFP-ESE-1 NES2Mut. DAPI panel - nuclear DAPI florescence (blue). GFP panel - GFP fluorescence
(green). Merge panel - an overlay of the DAPI and GFP fluorescence. (C) Anchorage-independent growth of pooled MCF-12A cell populations
expressing GFP-only, GFP-PEA3, GFP-ETS-2, GFP-ESE-1 or GFP-ESE-1 NES2Mut. Stable transfectants were plated in soft agarose and typical colonies
were photographed eight days later (40X). (D) Quantitation of anchorage-independent colony formation. Two independent, stably transfected
MCF-12A populations for each construct (GFP-only, GFP-PEA3, GFP-ETS-2, GFP-ESE-1 and GFP-ESE-1 NES2Mut) were seeded in triplicate soft agarose
cultures and colonies visible by 6X bright field microscopy were counted 21 days later. Bars show average numbers of colonies per plate +/- s.e.m.
(E) RT-PCR analysis of mRNA expression of GFP fusion constructs in stably transfected MCF-12A cells. For each construct two independently
generated stable populations (A and B) were analyzed: GFP-only populations (GFP-only A and B), GFP-PEA3 populations (PEA3 A and B), GFP-ETS-2
(ETS-2 A and B), GFP-ESE-1 (ESE-1 A and B), GFP-ESE-1 NES2Mut (ESE-1NES2MutA and B). PEA3 A (R) and PEA3 B (R) - RNAse treated samples.
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reagents to directly test whether cytoplasmically
restricted SAR protein is sufficient to initiate transfor-
mation. To this end, we generated two independent
stable MCF-12A transfectant cell populations for GFP-
NES1-SAR. As negative controls we generated stable
MCF-12A transfectant populations for the GFP-only
and GFP-NLS-SAR fusions, and as positive control we
generated stable transfectants for GFP-SAR. Figure 4A
shows representative subcellular GFP fluorescence pat-
terns for MCF-12A cells stably expressing the GFP,
GFP-SAR, GFP-NLS-SAR and GFP-NES1-SAR proteins.
Note that while Figures 1 and 2 show GFP fluorescence
patterns in transiently transfected MCF-12A, Figure 4A
shows stable transfectants. As shown in Figure 4A, in
each case, stable fusion protein localization is identical
to that observed in transient transfectants. Specifically,
GFP-only and GFP-SAR are both nuclear and cytoplas-
mic, the GFP-NLS-SAR is exclusively nuclear and stable
GFP-NES1-SAR is exclusively cytoplasmic (Figure 4A).
This restricted localization of GFP-SAR constructs is
further corroborated in large-field images of transiently
transfected MCF-12A and HeLa cells (Additional file 1).
Of note, the selection of the GFP-NLS-SAR and GFP-
NES1-SAR constructs for this experiment was arbitrary;
any GFP-SAR fusion targeted to the nucleus (i.e. GFP-
NLS1-SAR, GFP-NLS2-SAR, or GFP-NLS4-SAR, Figure
1C) or to the cytoplasm (GFP-NES2-SAR, Figure 2B)
should function equivalently to the respective constructs
chosen for analysis here (GFP-NLS-SAR and GFP-
NES1-SAR). To test the transforming function of each
stably expressed protein, each of the two independent
stable MCF-12A transfectant cell populations were used
to seed triplicate soft agarose cultures and colonies in each
culture were quantitated at 21 days post seeding (Figure
4B). Quantitation studies revealed that the GFP-only and
GFP-NLS-SAR negative control stable MCF-12A transfec-
tants formed ~269 colonies and ~305 colonies, respec-
tively (Figure 4B), demonstrating that GFP-NLS-SAR and
the GFP-only are equivalently deficient in transforming
function. In contrast, stable GFP-SAR and GFP-NES1-
SAR expression produced ~1979 and ~1022 colonies,
respectively (Figure 4B), revealing that both constructs
transform cells, although NES-SAR shows 50% reduced
colony formation. These data establish that cytoplasmi-
cally-restricted ESE-1 SAR domain is sufficient to trans-
form MCF-12A cells.
An intact SAR domain is required for optimal
transforming activity
Having shown that the SAR domain is necessary and suf-
ficient to initiate transformation of benign MECs [13], we
next sought to fine map the subregions within the SAR
domain that are essential for MEC transformation. To
this end, we generated GFP-SAR mutants, in which we
sequentially replaced 11-14 amino acid blocks of the SAR
domain, in-frame, with 8-11 amino acid sequences of the
Myc epitope, derived from the human c-myc protein, and
we tested the ability of the resulting constructs to trans-
form MCF-12A cells. Specifically, we replaced SAR
amino acids 1-14 (SAR-myc Box 1, replaced AAs corre-
spond to ESE-1 AAs 189-202), SAR amino acids 15-27
(SAR-myc Box 2, ESE-1 AAs 203-215), and SAR amino
acids 28-40 (SAR-myc Box 3, ESE-1 AAs 216-228), each
Figure 4 Stable expression of the cytoplasmically restricted
GFP-NES1-SAR protein is sufficient to transform MCF-12A Cells.
(A) Fluorescence imaging of stably expressed GFP-only, GFP-SAR,
GFP-NLS-SAR and GFP-NES1-SAR in living MCF-12A cells. Green -
GFP fluorescence. White dashed lines represent cell outlines. (B)
Quantification of anchorage-independent colony formation of
pooled MCF-12A cell populations stably expressing the GFP-only,
GFP-SAR, GFP-NLS-SAR or GFP-NES1-SAR proteins. Two independent,
stably transfected MCF-12A populations for each construct were
seeded in triplicate soft agarose cultures and colonies visible by 6X
bright field microscopy were counted 21 days later. Bars show
average numbers of colonies per plate +/- s.e.m.
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Page 7 of 15targeting sequential amino acid blocks of the 40-AA SAR
domain (Figure 5A). As a control we also replaced amino
acids 41-50, just distal to the SAR domain (SAR-myc Box
4, ESE-1 AAs 229-239), (Figure 5A). For each GFP-SAR
mutant we generated three separate MCF-12A stable
transfectant cell populations, and each stable transfectant
population was then used to seed triplicate soft agarose
cultures. Colony counts, performed 21 days post seeding,
revealed that SAR-myc Box 1, SAR-myc Box 2 and SAR-
myc Box 3 stable transfectants formed 1117, 1105, and
975 colonies, respectively, while SAR-myc Box 4 control
transfectants formed 1823 colonies (Figure 5B). Thus,
MCF-12A cells transfected with SAR-myc Box 1, SAR-
m y cB o x2a n dS A R - m y cB o x3c o n s t r u c t sf o r m e d5 0 %
less colonies than cells transfected with either intact
GFP-SAR (1987 colonies, Figure 4C & Figure 5B, purple
bar) or control SAR-myc Box 4 transfectants. This result
reveals that while SAR-myc Box 1, SAR-myc Box 2, and
SAR-myc Box 3 mutants are capable of conferring the
transformed phenotype to MCF-12A cells, their trans-
forming activity is reduced by 50% compared to GFP-
SAR, indicating that an intact SAR domain is required
for the full transforming effect.
The SAR domain contains the epitope for anti-ESE-1
mAb405
The ability of the SAR domain to initiate transformation
via a cytoplasmic mechanism most likely requires SAR
interaction with other proteins. To gain further insight
into the mechanism of SAR domain action, we examined
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ESE-1 AA#Aaaa189ddddddaaaaa203aaaaaaaaaa216aaaaaaaaaa229ggggggg239
aaaaaaaaaaaaaa│ssAsBox1Asssa│ssssBox2ssss│ssssBox3ssss│ssaBox4ss│ 
SAR-myc Box0  PSPGSSDVSTAGTGASRSSHSSDSGGSDVDLDPTDGKLFPSDGFRDCKKGD 
SAR-myc Box1  ------LISEEDLLASRSSHSSDSGGSDVDLDPTDGKLFPSDGFRDCKKGD 
SAR-myc Box2  PSPGSSDVSTAGTGEQKLISEEDLL--DVDLDPTDGKLFPSDGFRDCKKGD 
SAR-myc Box3  PSPGSSDVSTAGTGASRSSHSSDSGGSEQKLISEEDLL--SDGFRDCKKGD 
SAR-myc Box4  PSPGSSDVSTAGTGASRSSHSSDSGGSDVDLDPTDGKLFPEQKLISEED-- 
Figure 5 An intact SAR domain is required for optimal transforming activity. (A) Amino acid sequence of the SAR portion of GFP-SAR
(SAR, top row) followed by sequences of GFP-SAR-myc Box 1 - Box 4 mutants, containing in-frame replacement of SAR domain amino acids 1-
14 (SAR-myc Box 1, replaced AAs correspond to ESE-1 AAs 189-202), SAR amino acids 15-27 (SAR-myc Box 2, replaced AAs correspond to ESE-1
AAs 203-215), SAR amino acids 28-40 (SAR-myc Box 3, replaced AAs correspond to ESE-1 AAs 216-228), and amino acids 41-50, just distal to the
SAR domain (SAR-myc Box 4, replaced AAs correspond to ESE-1 AAs 229-239). Black capital letters on gray background - SAR sequence. Black
capital letters on white background - carboxy-terminal ESE-1 flanking sequence. Boxed red letters - myc epitope amino acids. Numbers above
the SAR sequence indicate corresponding amino acid locations in the ESE-1 protein. (B) Quantification of anchorage-independent colony
formation of pooled MCF-12A cell populations stably expressing GFP-SAR-myc Box 1 - Box 4 constructs (SAR-myc Box 1 - Box 4). Three
independent, stably transfected MCF-12A populations for each construct were seeded in triplicate soft agarose cultures and colonies visible by
6X bright field microscopy were counted 21 days later. Colony numbers formed by GFP-SAR transfectants (SAR, purple bar), included here to
facilitate comparison between SAR-myc Box 1-4 mutants and GFP-SAR control population, are reproduced from Figure 4C. Bars show average
numbers of colonies per plate +/- s.e.m.
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Page 8 of 15whether the SAR domain is surface exposed, and there-
fore has the potential to mediate protein-protein interac-
tions. As a test of whether the SAR domain is surface
exposed, we generated monoclonal antibodies to an anti-
gen spanning ESE-1 amino acids 129-259, containing the
TAD through AT hook domains of ESE-1 and tested
whether any of these antibodies could recognize the SAR
domain. Using the panel of anti-ESE-1 monoclonal anti-
bodies in Western blot analysis, we found that mAb405
recognized the SAR domain with high affinity (data not
shown). To map the precise region of SAR that interacts
with mAB405 antibody we took advantage of the four
aforementioned SAR-myc box mutants, and performed
immunofluorescence analysis of MCF-12A cells trans-
fected with these constructs (Figure 6). As shown in
Figure 6, monoclonal antibody mAB405 detected intact
GFP-SAR, as well as mutants SAR-myc Box 1, Box 2, and
Box 4, revealing that amino acids 189-215 of the SAR
domain and amino acids 229-239 just distal to the SAR
domain do not contain the mAB405 epitope. However,
the immunofluorescence signal was completely lost with
the Box 3 mutant spanning amino acids 216-228 of the
SAR domain, indicating that this 13-AA SAR fragment
contains the mAB405 epitope. This finding identifies
ESE-1 amino acids 216-228 as an antibody-accessible
region, which is likely to be surface-exposed and readily
accessible for protein-protein interactions.
Discussion
ETS family proteins have been shown to function in the
nucleus as regulators of gene transcription [1-4]. How-
ever, despite previous documentation of ESE-1 transcrip-
tion factor function [12,13,20,27-30], we have proposed a
novel nontranscriptional, cytoplasmic model whereby
ESE-1, functioning via its SAR domain, initiates mam-
mary epithelial cell transformation [13]. For ESE-1 to
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Figure 6 The SAR domain contains the region that binds a-ESE-1 mAB405 antibody. Immunofluorescence and direct fluorescence images of
MCF-12A cells transiently transfected with GFP-SAR (SAR) and GFP-SAR-myc Box 1 - Box 4 mutant constructs (labeled SAR-myc Box 1 - SAR-myc
Box 4, respectively). All cells were stained with anti-ESE-1 antibody mAB405 followed by secondary anti-mouse IgG conjugated to Cy3. DAPI - blue
channel, DAPI fluorescence. Cy3 (aESE-1) - red channel, indirect immunofluorescence signal indicating binding of mAB405. GFP - green channel,
direct fluorescence of GFP fusion protein. Merge - overlay of blue, red and green channels.
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Page 9 of 15mediate transformation from a cytoplasmic location,
ESE-1 must contain a functional nuclear export
sequence. In this report, we used molecular and pharma-
cological methods to define functional NLS and NES
sequences within human ESE-1 and to characterize the
critical role of nuclear export of ESE-1 in its transforming
function. Furthermore, we demonstrated that cytoplasmi-
cally-restricted SAR domain is sufficient to initiate MEC
transformation and that full transforming activity
requires an intact SAR domain.
ESE-1 has been documented to operate as a nuclear
activator of promoter function in transient transfection
reporter assays [28-30]. Indeed, transient transfection of
GFP-ESE-1 into several different cell lines, including
HeLa cervical carcinoma and T47D and SKBR-3 breast
cancer cells, demonstrates nuclear localization of this
fusion protein (data not shown). In this report we use
progressive truncations in GFP-fusion gain-of-function
studies to map ESE-1 nuclear localizing activity to a
basic, six AA sequence (
242HGKRKR
247)l o c a t e dw i t h i n
the A/T Hook domain, but outside of the ESE-1 DBD
(Figures 1A, B, & 1C). We confirmed that the DBD
does not contain an NLS sequence required for nuclear
localization of ESE-1, using a loss-of-function deletion
study of the ESE-1 DBD, demonstrating that DBD dele-
tion does not impair ESE-1 nuclear import (Figure 1E).
Furthermore, we have previously reported that in-frame
deletion of the ESE-1 A/T Hook domain (AAs 236-267),
which includes the functional ESE-1 NLS identified
here, completely inhibits ESE-1 nuclear import [13].
Indeed, Elf3, the murine ortholog of ESE-1, has been
shown to contain a functional NLS located at an equiva-
lent position and, in contrast to ESE-1, an additional
NLS in its DBD [21]. Interestingly, while both Elf3 NLS
motifs function autonomously in fluorescent protein-
fusion assays, they appear to target to different subnuc-
lear regions. However, since neither of the Elf3 NLS
motifs has been individually mutated or deleted in the
context of full-length Elf3, the requirement of either
NLS in Elf3 nuclear targeting remains unknown. Never-
theless, our data confirm that the functional ESE-1 NLS
resides within the A/T hook domain and that ESE-1
DBD is neither necessary nor sufficient to mediate ESE-
1 nuclear localization. This finding is surprising in light
of previous reports demonstrating an essential role for
the highly conserved ETS DBD in ETS factor nuclear
localization [17-19]. Finally, amino acid comparison ana-
lyses performed by us and others [31] reveal that the
ESE-1 NLS discovered here is not present in any other
ETS factor, including other members of the ESE
subfamily.
Extensive evidence supports nuclear-cytoplasmic shut-
tling as a regulatory mechanism for ETS protein function
[32-35]. A common regulatory mechanism involves
MAPK signaling cascades, which trigger nuclear export
of ETS repressors such as NET (new ETS), YAN, ERF
(ETS-2 Repressor Factor) and TEL (Translocation
ETS Leukemia) and thus release ETS-mediated gene
repression. For example, the ETS DBD of the ternary
complex factor NET contains a functional, CRM1-
dependent NES (
7LWQFLLQLLL
16)t h a ta p p e a r st ob e
highly-conserved within the DBDs of most ETS proteins
[32], including ESE-1 (i.e. NES2:
275LWEFIRDILI
284).
Activation of the c-Jun N terminal kinase kinase (JNKK)
pathway mediates nuclear exclusion of NET, relieving
transcriptional repression induced by NET. Moreover,
site-specific mutation of the NET NES traps NET in the
nucleus, resulting in increased NET repressor function
[32]. These data point to a crucial regulatory role for the
NET NES.
In this report, we identify two ESE-1 NES signals, NES1
and NES2, but we demonstrate that only one, NES2,
plays a critical role in the nuclear export and transform-
ing function of intact ESE-1 protein. NES1 is located in
the ESE-1 Pointed domain but appears to mediate
nuclear export, in a CRM1-dependent manner, only
when outside of the context of full length ESE-1 protein
(Figure 2C). In addition, comparative analysis of ETS fac-
tors Pointed domain sequences reveals that most other
ETS factors, including ESE-2 and ESE-3, do not conserve
the NES1 motif. In contrast, NES2 appears to be well
conserved in the DBD region of most ETS proteins, sug-
gesting a conserved function of this motif in the ETS
family (analysis not shown). Here we show that inactivat-
ing mutations in the ESE-1 NES2 completely inhibit
GFP-ESE-1 transforming function (Figures 3C & 1D),
indicating that GFP-ESE-1 nuclear export plays an essen-
tial role in GFP-ESE-1-mediated transformation. An
alternative to this conclusion is that mutation of DBD-
embedded NES2 disrupts ETS DBD-DNA binding and
that it is this disruption, rather than the inhibition of
NES2 function, that impairs GFP-ESE-1 transforming
activity. However, crystallographic structural data for the
DNA-bound ESE-1 DBD indicate that NES2 is localized
to a DBD subregion that does not make direct contact
with target DNA, except for leucine 275 [36]. This find-
ing is consistent with our previously published data
showing that the domains of ESE-1 that are required for
transcription factor function (e.g. the ESE-1 TAD) are
not necessary to initiate transformation in benign MECs,
whereas the SAR domain alone is sufficient in this type
of transformation assay (Figure 4) [13]. As noted above,
the ESE-1 NES2 is similar in sequence and location to
the functional MAPK-regulated NES motifs in NET and
ERF. However, we have been unable to identify any speci-
fic kinase(s) that regulate ESE-1 subcellular localization.
Specifically, co-transfection studies using constitutively
active forms of JNK, MAPK, ERK and v-SRC protein
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cytoplasmic shuttling of transiently co-expressed nuclear
GFP-ESE-1 (data not shown). Taken together, our data
suggest that basal ESE-1 subcellular localization repre-
sents the summed influences of NES and NLS functions.
Ak e yf i n d i n gi nt h i sr e p o r ti st h a tt h eE S E - 1S A R
domain alone, as GFP-NES-SAR, can be stably and speci-
fically targeted to the cytoplasm in MCF-12A cells and
that this cytoplasmic localization is sufficient to initiate
MEC transformation (Figure 4). The decreased transfor-
mation potency of GFP-NES-SAR vs. GFP-SAR observed
in our study is most likely due to the differential levels of
expression of GFP-NES-SAR vs. GFP-SAR. However,
another possible explanation of this result is that the
nuclear fraction of SAR contributes to the transforma-
tion, even though it is insufficient to evoke any transfor-
mation effect by itself. Furthermore, all of the data to
date point to the likely requirement that the SAR domain
interacts with other protein(s) to initiate transformation.
Supporting this notion are the observations that amino
acids 216-228 are accessible to mAB405 (Figure 6), and
that Pak-1 phosphorylates serine 207, with b-TrCP ubi-
quitinating the S207-dephosphorylated form and target-
ing it for proteosome-mediated degradation [37]. Indeed,
the report by Manavathi et al. [37] provided important
insights into the mechanisms of transformation initiation
in benign MCF-12A MECs by ESE-1, revealing that Pak-
1 mediated phosphorylation of serine 207 within the SAR
domain, results in increased protein stability and
increased transformation potency of ESE-1 [37]. Of note,
site-specific mutation of serine 207 to alanine resulted in
50% loss of soft agar colony formation, which is consis-
tent with our SAR-myc Box 2 data, also showing 50%
reduction (Figure 5). However, mutation of Box 1 and
Box 3 which span the amino- and carboxy- terminal
regions of the SAR domain, respectively, also resulted in
about 50% loss of transformation activity (Figure 5), sug-
gesting that an intact three-dimensional structure of the
SAR domain is required for optimal transformation
potency. One caveat in this study was that myc Boxes 1,
2, and 3 all contain the sequence LISEEDLL, while in
myc Box 4 the two terminal “LL” amino acids are miss-
ing. This may lead to an alternative interpretation that
the LISEEDLL motif within the myc sequence functions
as an active inhibitor of transformation, and that the two
terminal “LL” amino acids are required for inhibitor
function. To gain further insight of the key structure-
function aspects of the SAR domain, we performed a
phylogenetic analysis of SAR domain protein sequences
derived from fifteen different species, of which fourteen
are mammalian, in order to identify the most conserved
regions (Figure 7). This comparison revealed that the
SAR domain is found only in ESE-1 orthologs and in no
other proteins in the NCBI database (not shown).
However, the SAR domain is highly conserved among
mammals, with a clear reduction in conservation in the
chicken SAR sequence (Figure 7). Furthermore, there
appear to be two highly conserved subregions: amino
acids 189-198 and amino acids 208-220. While the con-
served amino terminal region appears not to contain any
known functional motifs, the region containing amino
acids 208-220 coincides with the PEST sequence,
209SSDSGGSDVD
218 identified previously [37], and a
highly conserved putative CKII phosphorylation site,
217SDVD
220.H o w e v e r ,S 2 0 7i sm u t a t e dt op r o l i n ei n6
out of 15 species in the database.
Conclusions
Our data precisely define NLS and NES signals in the
human version of ESE-1 that play a pivotal role in regu-
lating its subcellular localization and its ensuing trans-
forming function. Furthermore, we report that
transformation of human MECs requires an intact SAR
domain that can be targeted exclusively to the cytoplasm,
and that the SAR motif is accessible for protein and/or
ligand interactions. This report is important, since it pro-
vides critical mechanistic details of ESE-1 function, and it
significantly expands our understanding of the role of
ETS factors in mammary cell transformation.
Methods
Mammalian cell culture
All cell lines were acquired from the American Type
Culture Collection (Manassas, VA) and were maintained
as described in [13].
GFP fusion vectors
All GFP-SAR fusion constructs were generated using the
previously described PCR-based strategy [13] and sub-
cloned into the pEGFP-C3 parental expression plasmid
(Invitrogen Inc., Carlsbad, CA). Specific sense primers for
GFP-SAR fusions were: 5’-c g g gaattcatcccaagcacgggaagcg-
gaaacgaTCCCCTGGCAGCTCTG (GFP-NLS1-SAR); 5’-
ccggaattcataagaagggggatcccaagcacgggaagcggaaacgaTCC
CCTGGCAGC (GFP-NLS2-SAR); 5’- cgggaattcatcgaaagc
tgagcaaagagtactgggactgtctcgagggcaagaagagcaagcacTCCC
CTGGCAGCTCTGAC (GFP-NLS3-SAR); 5’- cgggaattca-
taagcacgggaagcggaaacgaTCCCCTGGCAGCTCTG (GFP-
NLS4-SAR); 5’- cgggaattcatcacgggaagcggaa acgaTCCCCT
GGCAGCTCTG (GFP-NLS5-SAR); 5’-c g g gaattcatggcca
aaagaaaaagaacagcaacTCCCCTGGCAGCTCTG (GFP-
NLS6-SAR). 5’- cgggaattcatctctgcaattgtgcccttgaggagctgcg
tctgTCCCCTGGCAGCTCTG (GFP-NES1-SAR); 5’- cggg
aattcatctctgcaattgtgccgccgaggaggcccgtctgTCCCCTGGCA
GCTCTG (GFP-NES1Mut-SAR); 5’-c g g gaattcatctgtgg-
gagttcatccgggacatcctcatcTCCCCTGGCAGC (GFP-NES2-
SAR); 5’-c g g gaattcatctgtgggagttcgcccgggacgccctcatcTC
CCCTGGCAGC (GFP-NES2Mut-SAR); Bold sequences
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coding sequence and NES/NLS sequences are underlined.
Generation of GFP-ESE-1ΔDBD and GFP-ESE-1 NES2-
Mut was accomplished using a two-step PCR overlap
extension strategy [38,39]. In both cases, the 5’ ESE-1
sense primer [13] was used with the following antisense
primers to generate the 5’ segment of each construct,
respectively: 5’-GGCAAAAACTCAAGCGGCTGGAAG
(GFP-ESE-1ΔDBD antisense) and 5’-GATGAGGGC
GTCCCGGGCGAACTCCCACAG (ESE-1 NES2Mut
antisense). To generate 3’ overlap segments, the 3’ ESE-1
antisense primer [13] was used with the following respec-
tive sense primers: 5’-AGTTTTTGCCGTGGGTGC
CTCTG (GFP-ESE-1ΔDBD sense) and 5’-C T G T G
GGAGTTCGCCCGGGACGCCCTCATCCACCCGGA
GCTCAACGAG (ESE-1 NES2Mut sense). The resulting
PCR overlap extension products were ligated into the
pEGFP-C3 plasmid as described previously [13]. Similar
PCR strategy, followed by ligation into pEGFP-C3 plasmid,
was used to generate GFP-SAR-myc Box 2 and GFP-SAR-
myc Box 3 constructs. In both cases, 5’ SAR sense primer
[13] was used with the following respective antisense pri-
mers to generate the 5’ segments of each construct: 5’-
gtcttcctcgctgatcagtttctgctcACCAGTCCCTGCGGTGGAG
(GFP-SAR-myc Box 2 antisense), 5’- gtcttcctcgctgat-
cagtttctgcTCACTTCCACCGGAGTCTGAGG (GFP-SAR-
myc Box 3 antisense). Whereas, the 3’ SAR antisense
primer [13] was used with the following respective sense
primers to generate the 3’ segment of each construct: 5’- c
tgatcagcgaggaagacctgttgGACGTGGACCTGGATCCC
ACTG (GFP-SAR-myc Box 2 sense), 5’- ctgatcagcgaggaa-
gacctgttgAGCGATGGTTTTCGTGACTGC (GFP-SAR-
m y cB o x3s e n s e ) .T op r o d u c et h eG F P - S A R - m y cB o x1
construct, the following sense primer was used in a PCR
with the 3’ SAR antisense primer [13]: 5’- ccggaattcatctgat-
cagcgaggaagacctgttgGCTTCTCGGAGCTCCCACTCC.
Similarly, the GFP-SAR-myc Box 4 sequence was ampli-
fied using the following antisense primer in a PCR with
ESE-1 AA#Aaaa   AAAA  189dddaaaAAaaa203aaaaaAAaaa216aaaaaaAAaa229gg agAg239 
A         │AAAAABox1AAAA│AAaABox2AAAA│AAaABox3AAAA│AAABox4AA│%id.
Homo sapiens (human)            PSPGSSDVSTAGTGASRSSHSSDSGGSDVDLDPTDGKLFPSDGFRDCKKGD     
Pan troglodytes (chimpanzee)   PSPGSSDVSTAGTGASQSSHSSDSGGSDVDLDPTDGKLFPSDGFRDCKKGD  98%
Pongo abelii (sumatran orangutan) PSPGSSDVSTAGTGASRSSHSSDSGGSDVDLDPTDGKLFPSDGFPDCKKGD  98%
Callithrix jacchus (common marmoset) PSPGSSDISTTGTGTSRSSHSSDSGGSDVDLDPTDSKLFPSDSFPDCKKGD  88%
Oryctolagus cuniculus (rabbit)   PSPGSSDVSTAGTGASQGSHSSDSGGSDVDLDPPDSKLFPRDGYPDCKKVD  84%
Macaca mulatta (rhesus macaque) AGELLDDVSTAGTGASRSSHSSDSGGSDVDLDPTDSKLFPRDGFPDCKKGD  82%
        F  
Monodelphis domestica (opossum) PSPGSSDVSTSGTGTSQSPH-SDSGGSDVDLDPTDNKLFPSDNFPDYKKGD  81%
Ailuropoda melanoleuca (giant panda) PSPGSSDVSTTGTGTSQSPHSSDSGGSDVDLDPSDSKLFCRDGFPDYKKGD  80%
Canis familaris (dog)       LSPGSSDVSTAGTATSQSPHSSDSGGSDVDLDPTDSKLFSRDGFPDYKKGD 80%
Bos Taurus (cow)     PSPGSSDVSTTGTGASQSPHASDSGGSDVDLDAPDSKLFPGDGFPDYKKGE  78%
Equus cabalus (horse)    PSPGNSDVSTAGTGASQSSHSSDSGGSDVDLDPTDSKLFSSGEWREPPRGD  78%
Rattus Norvegicus (rat)  PSPGSSDFSTSGTDTPQSSHSSDSGGSDVDLDLTDSKVFPRDGFPDYKKGE  74%
Mus musculus (mouse)  PSPGSSDVSTARTATPQSSHASDSGGSDVDLDLTESKVFPRDGFPDYKKGE  72%
                                                    FT 
Ornithorhynchus anatinus (platypus) TSPGNSDVSTSGTGTSQSPNSSDSGGSDLDPDPTDTKLFPQGVFTDHKKGD  68%
Gallus gallus (chicken)    MSPGSSDLS--GPVMSHSPNSQDSGGSDLDLDPMEAKLFPEDGFAGSKKGD  63%
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Figure 7 Alignment of SAR sequences from 15 species retrieved from the NCBI database. (A) Amino acid sequences of SAR domains from
15 species found in NCBI database http://blast.ncbi.nlm.nih.gov ordered according to percent identity to human SAR amino acid sequence. Gray
background - AAs identical to human sequence. Yellow background - conservative substitutions. Red background - conserved regions. Black
angled lines - insertions. %id. - percent identity to human protein sequence. Conservative substitutions and gaps were regarded as non-identical
AAs for calculations of percent identity. (B) Percent conservation at each AA position between human and the remaining 14 species listed in (A).
Conservative substitutions and gaps were considered non-identical amino acids for the purpose of calculation of percent conservation. Red
ellipses - conserved subregions of SAR.
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cagtttctgctcGGGGAAGAGCTTGCCATC. Both sequences
were ligated into the pEGFP-C3 EcoR I site, to produce
the GFP-SAR-myc Box 1 and GFP-SAR-myc Box 4 con-
structs, respectively. For each primer used in generation of
GFP-SAR-myc Box mutants, capital letters show SAR
domain coding sequence, and italicized text shows myc
epitope sequence. To generate the pEGFP-PEA3 and
pEGFP-ETS-2 expression plasmids, the full-length human
PEA3 and ETS-2 coding sequences were amplified by RT-
PCR from T47D human breast cell line whole cell RNA.
The respective primer pairs used in these amplifications
were as follows: 5’-cgagatctccggaattcatATGGAGCGG
AGGATGAAAGCCGG vs. 5’-cgagatctccggaattcatCTAG-
TAAGAGTAGCCACCCTTG (PEA3) and 5’-cgagatctccg-
gaattcatATGAATGATTTCGGAATCAAG vs. 5’-cgag
atctccggaattcatTCAGTCCTTCGTGTCGGGC (ETS-2).
In each case, restriction sites are in bold, and start and
stop codons are underlined. Each full-length coding
sequence was then ligated into the pEGFP-C3 plasmid as
described [13]. The absence of mutations in each expres-
sion construct was confirmed by DNA sequencing.
Fluorescence microscopy
MCF-12A cells were transfected with GFP-fusion
expression plasmids and plated as described previously
[13]. Alternatively, stable MCF-12A transfectants were
plated directly onto glass coverslips for confocal micro-
scopy. For nuclear staining, some cover slips were
stained with 300 nM 4’,6-diamidino-2-phenylindole
(DAPI) [13]. In addition, some coverslips were incubated
for 15 minutes at 37°C in PBS containing 10 ng/ml lep-
t o m y c i nB( S i g m a - A l d r i c h ,I n c . ,S t .L o u i s ,M O ) .C e l l
imaging and image acquisition were performed as
described previously [13].
Stable cell lines
Stable MCF-12A cell expression of each GFP fusion
protein was obtained as described in [13] and two or
three independent stable transfectant populations were
generated for each expression plasmid.
Soft agarose assays
Triplicate soft agarose cultures were prepared for each
stable MCF-12A transfectant population, as described in
[13]. Each experiment was repeated as noted in the text.
Representative colonies were imaged and quantitated as
described in [13].
RT-PCR
Whole cell RNA was prepared from individual stable
transfectant populations using an RNA STAT-60 kit (Tel-
test, Inc., Friendswood, TX). GFP fusion transcripts in
each RNA sample were identified using a sense primer
directed against a terminal portion of the GFP open-
reading frame and an antisense primer specific for a tran-
scribed but untranslated sequence immediately down-
stream of the DNA insertion site in the pEGFP-C3
plasmid. The Omniscript™ RT kit (Qiagen) was used for
reverse transcription as described in [13]. Some RNA sam-
ples were treated with RNAse A (Five Prime Three Prime,
Inc., Boulder, CO) prior to reverse transcription. All RT-
PCRs were analyzed by 1% agarose gel electrophoresis.
Immunofluorescence
Cells were plated directly onto glass cover slips in a 12-
well tissue culture plate andt r a n s f e c t e dw i t hG F P - S A R
constructs using Effectene (Qiagen). Two days post-plat-
ing, cells were fixed with 2% paraformaldehyde for 20-25
min at room temperature and washed with phosphate-buf-
fered saline (PBS). Subsequently, cells were permeabilized
with 0.5% Triton X-100 in PBS for 10 minutes, followed
by three washes in 100 mM glycine in PBS. Permeabilized
cells were blocked in blocking buffer containing 0.5%
Tween-20, 10% goat serum in PBS for 1-2 h. Cells were
incubated with anti-ESE-1 monoclonal antibody mAB405
[16] diluted 1:500 in the blocking buffer overnight at 4°C.
After washes, cells were incubated for 1 h with Cy3-conju-
gated donkey anti-mouse IgG secondary antibody (Jackson
Immunoresearch). Nuclei were counterstained using
300 nM DAPI (Invitrogen, #D-1306).
Alignments of SAR protein sequences
Amino acid sequences were retrieved from non-redun-
dant protein sequences NCBI database using BLASTP
2.2.24+ program and the human SAR sequence (ESE-1
AAs 189-239) as a query (http://blast.ncbi.nlm.nih.gov/,
[40]). For the purpose of calculation of percent identity
to human sequence, conservative substitutions and gaps
were considered as non-identical amino acids. When
there was an insertion, percent identity was calculated
with the number of amino acids in the longer protein as
the denominator. For the purpose of calculation of per-
cent conservation at a given AA position between human
and the remaining species, conservative substitutions and
gaps were considered as non-identical amino acids, while
insertions were excluded from analysis.
Additional material
Additional file 1: Supplemental Figure 1. Large-field fluorescent
images of MCF-12A cells and HeLa cells transiently transfected with GFP
alone, GFP-SAR, GFP-NES-SAR, or GFP-NLS-SAR.
Abbreviations
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